XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Nonredeemable Noncontrolling Interests
Beginning balance (in shares) at Jan. 28, 2023   54,609,786          
Beginning balance at Jan. 28, 2023 $ 572,751 $ 546 $ 532,398 $ 1,276,857 $ (134,073) $ (1,141,615) $ 38,638
Beginning balance (in shares) at Jan. 28, 2023           88,161,467  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) (10,694)     (11,805)     1,111
Other comprehensive income (loss), net of income tax (4,095)       (5,404)   1,309
Issuance of common stock under stock compensation plans (in shares)   1,085,319       1,085,319  
Issuance of common stock under stock compensation plans (450) $ 11 (14,519)     $ 14,058  
Issuance of stock under Employee Stock Purchase Plan (in shares)   11,848       11,848  
Issuance of stock under Employee Stock Purchase Plan 181   28     $ 153  
Share-based compensation 4,620   4,617 3      
Dividends (12,662)     (12,662)      
Share repurchases (in shares)   (2,237,872)       (2,237,872)  
Share repurchases (42,821) $ (22) 22     $ (42,821)  
Equity component value of convertible notes transactions, net (744)   (744)        
Sale of common stock warrants 20,158   20,158        
Purchase of convertible note hedges (39,397)   (39,397)        
Termination of common stock warrants (1,024)   (1,024)        
Termination of convertible note hedges 7,235   7,235        
Ending balance (in shares) at Apr. 29, 2023   53,469,081          
Ending balance at Apr. 29, 2023 $ 493,058 $ 535 508,774 1,252,393 (139,477) $ (1,170,225) 41,058
Ending balance (in shares) at Apr. 29, 2023           89,302,172  
Beginning balance (in shares) at Feb. 03, 2024 53,007,966 53,007,966          
Beginning balance at Feb. 03, 2024 $ 734,794 $ 530 594,520 1,412,426 (137,010) $ (1,185,526) 49,854
Beginning balance (in shares) at Feb. 03, 2024 89,763,349         89,763,349  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings (loss) $ 15,906     13,022     2,884
Other comprehensive income (loss), net of income tax 599       (38)   637
Issuance of common stock under stock compensation plans (in shares)   779,872       779,934  
Issuance of common stock under stock compensation plans 5,649 $ 8 (4,682)     $ 10,323  
Issuance of stock under Employee Stock Purchase Plan (in shares)   9,740       9,740  
Issuance of stock under Employee Stock Purchase Plan 198   69     $ 129  
Share-based compensation 3,120   3,115 5      
Dividends (135,512)     (135,512)      
Share repurchases (in shares)   (326,429)       (326,429)  
Share repurchases (10,279) $ (3) 3     $ (10,279)  
Noncontrolling interest capital distribution (11,735)           (11,735)
Noncontrolling interest capital contribution 219           219
Sale of common stock warrants 3,665   3,665        
Termination of common stock warrants (548)   (548)        
Termination of convertible note hedges 1,044   1,044        
Settlement of convertible senior notes (in shares)   122,313       (122,313)  
Settlement of convertible senior notes 212 $ 1 (1,413)     $ 1,624  
Exercise of convertible notes hedges (in shares)   (90,729)       90,729  
Exercise of convertible notes hedges $ 0 $ (1) 2,558     $ (2,557)  
Ending balance (in shares) at May. 04, 2024 53,502,733 53,502,733          
Ending balance at May. 04, 2024 $ 607,332 $ 535 $ 598,331 $ 1,289,941 $ (137,048) $ (1,186,286) $ 41,859
Ending balance (in shares) at May. 04, 2024 89,268,520         89,268,520